New York Stem Cell Foundation

The New York Stem Cell Foundation (NYSCF)^[1] is an American 501(c)(3) nonprofit organization, founded in the Spring of 2005, with the mission “accelerating cures for the major diseases of our time through stem cell research.” NYSCF established the first privately funded stem cell laboratory in New York City, where NYSCF researchers and scientific collaborators conduct advanced stem cell investigations. The foundation supports stem cell scientists through the NYSCF Innovator Program, and it engages the academic, medical, pharmaceutical, and biotechnology communities by hosting the annual translational stem cell research conference and other symposia throughout the year. NYSCF aims to educate the public on the importance of stem cell research in new therapies.

The foundation focuses on three areas:

Susan L. Solomon is the CEO, and Kevin Eggan serves as the Chief Scientific Officer.

In 2005, Susan L. Solomon co-founded The New York Stem Cell Foundation with the mission of accelerating stem cell research to cure major disease. Solomon, an attorney with a previous career in business, started as a health-care advocate in 1992 when her son was diagnosed with type 1 diabetes. Following her son’s diagnosis and her mother’s death from cancer in 2004, she sought to find a way to translate medical research more quickly into cures. In conversations with scientists and clinicians, Solomon identified stem cells as the most promising way to address unmet patient needs. In 2006, NYSCF established its own laboratory, which is now one of the largest private stem cell laboratories in the United States, now referred to as The NYSCF Research Institute.

NYSCF channels private philanthropy toward stem cell research. NYSCF has raised nearly $100 million for stem cell research both in its own laboratory and in the major medical institutions around the world that it continues to support.

In March 2006, NYSCF opened the first privately funded human embryonic stem cell (hESC) laboratory in New York. The lab was free from federal restrictions and allowed scientists to conduct all types of stem cell research, including studies that involve embryonic stem cells, induced pluripotent stem cells, and somatic cell nuclear transfer.

...
Wikipedia